ROLE OF 25% DEXTROSE PROLOTHERAPY VERSUS EXTRA CORPOREAL SHOCKWAVE therapy in the treatment of chronic lateral epicondylitis

Recruiting

• Conditions: Lateral epicondylitis,

• Registration Number: CTRI/2019/10/021802
• Lead Sponsor: DEBASISH DEB

Brief Summary

This a randomized controlled trial comparing between 25% dextrose prolotherapy and extra-corporeal shock wave therapy in the management of pain and improving functional outcome in patients suffering from chronic lateral epicondylitis, sample size is 84,block randomisation is used, VAS and Grip strength assessment has been taken as primary outcome measures

Detailed Description

Not available

Study Timeline

• Study Start: 2019-05-11
• Last Update Posted: 2019-11-19

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

Duration of symptoms for at least 6 months Failed conservative treatment Willingness to comply with treatment and follow-up assessment.

Exclusion Criteria

Duration of symptoms less than 6 months History of previous surgery in the same tendon Implanted hardware adjacent to the target treatment region Abnormal radiographic findings like Osteophtyes, Calcification, or Exostosis pregnancy Diabetes Cancer.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
improvement in pain in terms of VAS	BASELINE, 1MONTH, 3MONTH, 6MONTH
improvement in functional outcome in terms of Grip strength	BASELINE, 1MONTH, 3MONTH, 6MONTH

Secondary Outcome Measures

Name	Time	Method
grip srtength assessment	at baseline, 1month,3 month, 6month

Trial Locations

Locations (1)

REGIONAL INSTITUTE OF MEDICAL SCIENCES; 🇮🇳 West, MANIPUR, India

REGIONAL INSTITUTE OF MEDICAL SCIENCES

🇮🇳West, MANIPUR, India

DEBASISH DEB

Principal investigator

8794019638

debasishdebpmr@gmail.com